|
 |
European BioPharmaceutical Review
|
| While being prepared in the event of a chemical or bioweapons attack was hardly a new subject to the powers that be in the US Government, 9/11 and the subsequent anthrax-laced letter incidents did much to galvanise biodefence efforts. Since those dreadful events, several billions of dollars have been spent in the US to improve our infrastructures, fill out our stockpiles and create new diagnostics, vaccines and therapeutics. Politics and sticky issues surrounding business tactics appear to be blocking progress, but at the same time advances in biotechnology are pointing the way to promising solutions. The question is this: can we figure out how to make it all work? |
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
Small Scale Biomanufacturing – clinical trials, cell & gene therapies
18 September 2008, Clifton Pavilion, Bristol Zoo Gardens, Bristol
This one day conference, sponsored by bioProcessUK and organised by BioApproaches South West, will cover key, important topics relating to small scale GMP biomanufacturing.
More info >> |
|
 |
News and Press Releases |
 |
“PACK DIFFERENT” with EMBALLAGE 2008
“Business, Innovation, Outlook” are the watchwords for the 38th World Packaging Exhibition which opens in Paris from 17 to 21 November 2008. Fifteen months before the key packaging event of the end of 2008, EMBALLAGE displays its differences to offer you a new edition that is even more representative, international and rich in new features.
More info >> |
|
 |
